Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (NDUFA5) is a nuclear-encoded accessory subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), which is located in the inner mitochondrial membrane and participates in the transfer of electrons from NADH to ubiquinone as part of the respiratory chain. While NDUFA5 is not directly involved in the catalytic activity of complex I, it is essential for complex stability and function, contributing to mitochondrial energy production via oxidative phosphorylation[1][5][6]. Mutations or dysregulation of NDUFA5 have been associated with specific mitochondrial disorders and have downstream effects on cellular metabolism[1][5].
Drugs that inhibit mitochondrial complex I (e.g., rotenone) inhibit the entire complex, not specifically NDUFA5
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (NDUFA5).